This gene decides how quickly your liver breaks down caffeine. Some people clear it in a few hours and sleep fine after an afternoon coffee; others feel jittery for half the day and lie awake at night from a single morning cup.
See your CYP1A2 variants — freeCYP1A2 is the liver enzyme that breaks down caffeine, melatonin, several antipsychotics and antidepressants, and aromatic amines from char-grilled meat. Activity varies up to 40-fold between people based on genetics (rs762551) and induction by smoking, cruciferous vegetables and certain medications.
Slow metabolizers (AC or CC at rs762551) who drink 2+ cups of coffee per day have elevated risk of hypertension, non-fatal myocardial infarction, and impaired glucose tolerance. Fast metabolizers (AA) may benefit from moderate coffee for cardiovascular and metabolic health. Caffeine sensitivity, sleep disruption and afternoon-crash patterns are practical signals.
| rsID | Alias | Risk allele | Effect | Frequency |
|---|---|---|---|---|
rs762551 | CYP1A2*1F (A→C) | C | C allele reduces enzyme inducibility; slower caffeine clearance. | C allele ≈30-40% |
| Genotype | Prevalence | What it means | What to do |
|---|---|---|---|
| AA (fast metabolizer) | ~40% | Caffeine cleared rapidly (half-life ~3-4h). | Moderate coffee (2-4 cups/day) often cardioprotective and metabolically neutral. Stop caffeine ~6h before sleep. |
| AC or CC (slow metabolizer) | ~60% | Caffeine lingers (half-life ~6-10h). | Cap caffeine at 200 mg/day (~1 cup of coffee). No caffeine after noon. Track resting BP if you drink daily. |
| Condition | Relationship | Detail |
|---|---|---|
| Hypertension | Increased risk in slow metabolizers with high intake | Slow metabolizers drinking 2+ cups/day have ~50% higher hypertension risk. |
| Non-fatal myocardial infarction | Increased risk in slow metabolizers | Cornelis 2006 JAMA: slow metabolizers showed dose-dependent MI risk; fast metabolizers showed protection. |
| Impaired glucose tolerance | Increased in slow metabolizers | High-dose caffeine impairs insulin sensitivity acutely; effect more pronounced in slow metabolizers. |
| Drug metabolism | Affects clozapine, olanzapine, theophylline, melatonin clearance | Relevant for psychiatry and pulmonology dosing. |
Diet can modestly tune CYP1A2 activity, but the main lever is caffeine dose itself, matched to genotype.
| Supplement | Typical dose | Form | Notes |
|---|---|---|---|
| L-theanine | 100-200 mg with each caffeinated drink | Suntheanine | Smooths caffeine response; reduces jitter without blunting alertness. |
| Magnesium glycinate | 200-400 mg/day, ideally evening | Glycinate | Counteracts caffeine-induced magnesium loss; supports sleep. |
| Sulforaphane (broccoli sprout extract) | 10-30 mg/day | Standardized extract | Induces phase-II detox enzymes downstream of CYP1A2. |
Beyond a DNA test, signs include feeling jittery for many hours after one coffee, disrupted sleep from afternoon caffeine, racing heart from a single espresso, or persistent afternoon energy from morning coffee.
1 cup/day or less is generally fine for most slow metabolizers. The risk signal appears at 2-4+ cups/day, especially with hypertension or family history of cardiovascular disease.
Tea contains less caffeine and adds L-theanine, which buffers the response. Slow metabolizers often tolerate moderate tea (2-3 cups) better than equivalent coffee.
Decaf is a reasonable swap if you enjoy the ritual. Note that decaf still contains 5-15 mg caffeine per cup — meaningful if you drink several.
Likely a CYP1A2 genotype mismatch. AA fast metabolizers clear caffeine 2-3x faster than CC slow metabolizers. Genetic testing makes the difference visible.
This page is informational and does not constitute medical advice, diagnosis or treatment. Genetic risk is one input among many — diet, exercise, sleep, environment and family history all matter. Consult a qualified healthcare professional before starting or stopping any supplement, medication or treatment.